JJ Wilson
Optimi Announces Closing of First Tranche of Non-Brokered Private Placement
28 févr. 2024 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), a Health Canada licensed drug researcher and...
160614-N-JF840-0001
NRL’s Blossom Point Tracking Facility Provides Command and Control for Space Development Agency Tranche 0 Mission Launch 2
05 sept. 2023 14h11 HE | U.S. Naval Research Laboratory
BLOSSOM POINT, MD, Sept. 05, 2023 (GLOBE NEWSWIRE) -- The U.S. Naval Research Laboratory’s (NRL) Blossom Point Tracking Facility (BPTF) provides command and control (C2) for the Space Development...
OptimiTM-03.jpg
Optimi Health Announces Second Tranche of CAD $1,000,000 Secured for Debt Financing
05 sept. 2023 07h30 HE | Optimi Health Corp.
VANCOUVER, British Columbia, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation...
NOTICE TO DISREGARD
NOTICE TO DISREGARD -- U.S. Naval Research Laboratory
02 sept. 2023 13h23 HE | U.S. Naval Research Laboratory
BLOSSOM POINT, MD, Sept. 02, 2023 (GLOBE NEWSWIRE) -- We are advised by U.S. Naval Research Laboratory that journalists and other readers should disregard the news release, “NRL’s Blossom Point...
download-2.png
Emerald Health Therapeutics Announces Second Tranche of $4.5 Million Financing
06 janv. 2020 07h00 HE | Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF), has entered into a binding term sheet with certain...
download-2.png
Emerald Health Therapeutics Closes Initial Tranche of Private Placement
30 déc. 2019 22h58 HE | Emerald Health Therapeutics Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 30, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”)...
Zenergy Brand, Inc..png
Zenergy Announces the Closing of $1.6M in Initial Funding, as Tranche 1 of a $10 Million Debenture Facility
15 janv. 2019 07h00 HE | Zenergy Brand, Inc.
DALLAS, TX, Jan. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Zenergy Brands, Inc. (OTCPK: ZNGY), the nation's leading next-generation utility, announced today it has closed a $10 Million...